<DOC>
	<DOCNO>NCT02934555</DOCNO>
	<brief_summary>To study effect ubiquinol `` metabolic resuscitator '' post-cardiac arrest .</brief_summary>
	<brief_title>Ubiquinol Metabolic Resuscitator Post-Cardiac Arrest</brief_title>
	<detailed_description>Cardiac arrest ( CA ) occur 400,000 patient United States year estimate mortality great 90 % . The majority patient resuscitate CA succumb neurologic morbidity associate post-CA syndrome ischemic-reperfusion injury . Currently , pharmacologic agent know offer survival benefit prevent devastate neurologic injury post-CA patient . A potential therapeutic target follow ischemia-reperfusion injury mitochondrial function injure cell and/or reduction oxygen free radical . Coenzyme Q10 ( CoQ10 ) essential mitochondrial co-factor free radical scavenger propose neuroprotective agent various neurodegenerative disorder well cardioprotective agent . CoQ10 furthermore show exciting preliminary result potential therapy post-CA . In order test effect ubiquinol `` metabolic resuscitator '' post-CA patient provide additional preliminary data large-scale clinical trial , investigator conduct randomized , double-blind , place-controlled trial ubiquinol post-CA patient .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Adult ( â‰¥ 18 year ) Cardiac arrest define cessation pulse require chest compression Not follow command ROSC Admission ICU Naso/orogastric tube Ability receive enteral medication Protected population ( pregnant woman , prisoner , intellectual disable ) Current CoQ10 supplementation Anticipated death within 24 hour &gt; 12 hour ROSC estimate randomization Jejunostomy tube ( Jtube )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>